TRUHVaneck Healthcare TruSector ETF

Grow my moneyNewRanked #2,240 of 2,960 in this goal

Seeks long-term capital appreciation.

By VanEck · Launched 2026

Annual Cost

0.10%

#539 of 5,562 · low cost

Fund Size

$0.5M

#5,527 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

2 months

#5,362 of 5,562 · young

Performance

Total-return NAV · USD

Growth of $10,000

$10,310+3.1%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Active selection

Sector

Health care

Focus

Biotech & Genomics

What it actually holds

By weight

Concentration

Top 10 holdings = 60.6% of fundconcentrated

Eli Lilly and CoLLY

16.1%

Johnson & JohnsonJNJ

10.0%

AbbVie IncABBV

7.1%

UnitedHealth Group IncUNH

6.4%

Merck & Co IncMRK

5.5%

Thermo Fisher Scientific IncTMO

3.4%

Amgen IncAMGN

3.4%

Gilead Sciences IncGILD

3.1%

Intuitive Surgical IncISRG

2.8%

Pfizer IncPFE

2.8%

Asset allocation

Stocks

99.6%

Cash

0.4%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

N/A

Max drawdown

-4.5%Mild

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks long-term capital appreciation.
Strategy: Actively managed fund investing primarily in equity securities of healthcare-related companies. Focuses on well-established market leaders in pharmaceuticals, biotechnology, and healthcare services, using a discretionary process to select investments.
Inception date: April 1, 2026
Fund family: VanEck